AZD9291 a novel EGFR-TKI that overcomes T790M-mediated resistance in NSCLC

Date 04 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Mutant-specific kinase inhibitors
Topics Cytotoxic agents
Clinical research
Non-small-cell lung cancer
Basic Scientific Principles
Therapy
Biological therapy
Presenter David Planchard